Bharat Biotech: Nose corona vaccine coming soon, Phase III trial completed
Bharat Biotech Nasal Vaccine , Corona infection continues in the country and around the world. Corona preventive vaccination is being emphasized around the world. However, a complete cure for corona has not been discovered yet. coronal nasal vaccine soon. Bharat Biotech Chairman of Dr. Krishna Ella has given important information in this regard. He said the third phase of the nasal vaccine trial has been completed. The company will submit the details of the nasal vaccine to the Drug Regulatory Authority of India (DGCI) next month.
Doctor. Ella said, “We have just completed the nasal vaccine trial and are currently analyzing the data. Information in this regard will be given to DGCI next month. These vaccines are likely to be approved by the DGCI if all are done properly. If approved, it would be the world’s first nasal vaccine.
Dr. Ella participated in the Viva Technology 2022 event in Paris. This time he has given important information about the nasal vaccine. He said that those who have taken the second dose of corona vaccine should take a booster dose. In January this year, the Indian Drug Administration approved Bharat Biotech for the third trial on a nasal vaccine.
He said that the booster dose of corona vaccine increases immunity. So a booster dose for every vaccination is a miracle dose. Even in children, two doses do not give much immunity, but the booster dose is very effective for children.
He said that even for adults, a booster dose of corona vaccine is very important. He further said that corona virus cannot be destroyed 100 percent. It will last forever and you have to live with it and protect yourself from it and control corona infection.